In a filing, Caris Life Sciences Inc revealed its insider Denton John Russel acquired Company’s shares for reported $0.16 million on Jun 20 ’25. In the deal valued at $21.00 per share,7,500 shares were bought. As a result of this transaction, Denton John Russel now holds 123,591 shares worth roughly $3.43 million.
Then, Brille Brian J bought 30,000 shares, generating $630,000 in total proceeds. Upon buying the shares at $21.00, the insider now owns 162,428 shares.
Wolfe Research initiated its Caris Life Sciences Inc [CAI] rating to an Outperform in a research note published on July 14, 2025; the price target was $32. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. JP Morgan began covering CAI with “an Overweight” recommendation on July 14, 2025. Guggenheim started covering the stock on July 14, 2025. It rated CAI as “a Buy”.
Price Performance Review of CAI
On Monday, Caris Life Sciences Inc [NASDAQ:CAI] saw its stock jump 4.56% to $27.72. Over the last five days, the stock has gained 4.49%. Nevertheless, the stocks have fallen -1.00% over the past one year.
Levels Of Support And Resistance For CAI Stock
The 24-hour chart illustrates a support level at 26.91, which if violated will result in even more drops to 26.10. On the upside, there is a resistance level at 28.36. A further resistance level may holdings at 29.01.
The most recent change occurred on July 14, 2025 when Evercore ISI began covering the stock and recommended ‘”an Outperform”‘ rating along with a $33 price target.
